Pfizer (PFE) Intangibles (2009 - 2026)

Pfizer (PFE) has 18 years of Intangibles data on file, last reported at $52.6 billion in Q1 2026.

• Intangibles for Q1 2026 came in at $52.6 billion, down 2.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $52.6 billion (down 2.63% YoY), and the FY2025 annual result was $53.7 billion, down 3.03% from the prior year.
• Intangibles fell to $52.6 billion in Q1 2026 per PFE's latest filing, from $53.7 billion in the prior quarter.
• Over five years, Intangibles peaked at $64.9 billion in Q4 2023 and troughed at $28.2 billion in Q4 2022.
• A 5-year average of $48.4 billion and a median of $52.6 billion in 2026 frame the typical range for Intangibles.
• The sharpest annual moves came in 2022 and 2024: Intangibles jumped 72.47% in 2022, then declined 14.62% in 2024.
• A 5-year view of Intangibles shows it stood at $43.4 billion in 2022, then jumped by 49.64% to $64.9 billion in 2023, then slipped by 14.62% to $55.4 billion in 2024, then retreated by 3.03% to $53.7 billion in 2025, then fell by 2.18% to $52.6 billion in 2026.
• Business Quant data shows PFE's Intangibles at $52.6 billion in Q1 2026, $53.7 billion in Q4 2025, and $51.3 billion in Q3 2025.